Wood Tarver Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-158
Closed -$10K 477
2025
Q2
$10K Hold
158
﹤0.01% 419
2025
Q1
$11K Buy
158
+125
+379% +$10.3K ﹤0.01% 408
2024
Q4
$2K Buy
+33
New +$3.57K ﹤0.01% 510

Other funds holding NVO

Wood Tarver Financial Group's NVO Position: Q3 2025 in Review

Wood Tarver Financial Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 158 shares — an estimated $10K sold.

Wood Tarver Financial Group first reported a position in NVO in Q4 2024 and held it in 3 quarters. The position peaked at $11K in Q1 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Wood Tarver Financial Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Wood Tarver Financial Group sold 158 Novo Nordisk shares in Q3 2025, an estimated $10K.
  • Wood Tarver Financial Group first reported a position in Novo Nordisk in Q4 2024 and held it in 3 quarters.
  • Wood Tarver Financial Group's Novo Nordisk position peaked at $11K in Q1 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Wood Tarver Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.